Bin Li is currently a Plasmid Manufacturing Leader at Sanofi, focusing on global harmonization and tech transfer since 2022. Prior to this role, Bin held various positions at Sanofi from 2017 to 2022, culminating as the Manager of the Pilot Plant in MSAT-Drug Substance. Bin's earlier experience includes serving as a Bioengineer and Fermentation Scientist at Eppendorf, Inc. from 2014 to 2017 and as a Senior Research Associate at Green Biologics, Inc. from 2013 to 2014. Bin is also pursuing a Doctor of Philosophy (Ph.D.) in Bioengineering at the University of Toledo.
This person is not in the org chart
This person is not in any teams
This person is not in any offices